Quick Answer
ICU MEDICAL INC/DE reported Stockholders Equity of $2.12 billion for the year ending 2025.
- ICU MEDICAL INC/DE showed an increase of +8.1% in Stockholders Equity from 2024 to 2025.
- This data is from ICU MEDICAL INC/DE's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2009: $261.09 million | Q1 2018: $1.23 billion | Q2 2018: $1.26 billion | Q3 2018: $1.26 billion | Q1 2019: $1.28 billion | Q2 2019: $1.32 billion | Q3 2019: $1.34 billion | Q1 2020: $1.38 billion | Q2 2020: $1.41 billion | Q3 2020: $1.45 billion | Q1 2021: $1.52 billion | Q2 2021: $1.56 billion | Q3 2021: $1.59 billion | Q1 2022: $2.18 billion | Q2 2022: $2.09 billion | Q3 2022: $2.10 billion | Q1 2023: $2.10 billion | Q2 2023: $2.11 billion | Q3 2023: $2.10 billion | Q1 2024: $2.07 billion | Q2 2024: $2.04 billion | Q3 2024: $2.05 billion | Q1 2025: $1.99 billion | Q2 2025: $2.12 billion | Q3 2025: $2.13 billion.
- Over the full 14 years of available data (2012 to 2025), ICU MEDICAL INC/DE's Stockholders Equity has grown by 443.4%.
- Historical annual values: Fiscal year 2025: $2.12 billion | Fiscal year 2024: $1.97 billion | Fiscal year 2023: $2.12 billion | Fiscal year 2022: $2.09 billion | Fiscal year 2021: $1.62 billion | Fiscal year 2020: $1.50 billion | Fiscal year 2019: $1.38 billion | Fiscal year 2018: $1.26 billion | Fiscal year 2017: $1.20 billion | Fiscal year 2016: $660.16 million | Fiscal year 2015: $579.87 million | Fiscal year 2014: $508.25 million | Fiscal year 2013: $464.73 million | Fiscal year 2012: $390.86 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: